Active ingredientDalbavancinCat. No. P-D006-001CAS 171500-79-1Family · Pharmaceutical analytical standards
Dalbavancin
A lipoglycopeptide antibiotic, a relative of vancomycin, approved in the United States in 2014 for acute bacterial skin and soft tissue infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It was first synthesised in Italy from a natural glycopeptide made by an actinomycete; it stays in the body so long (half-life of about two weeks) that two infusions a week apart are enough.
Go to the active ingredient →Active ingredientDalbavancinCat. No. P-D006-001CAS 171500-79-1
Active ingredientDalbavancin HClCat. No. P-D006-002CAS 2227366-51-8
Isotopically labelledDalbavancin-d6Cat. No. P-D006-004CAS 1126461-54-8
NitrosamineN-Nitroso Dalbavancin A0Cat. No. P-D006-006
NitrosamineN-Nitroso-Dalbavancin A1Cat. No. P-D006-008
NitrosamineN-Nitroso-Dalbavancin B0Cat. No. P-D006-009
NitrosamineN-Nitroso-Dalbavancin B1Cat. No. P-D006-010
NitrosamineN-Nitroso-Desmethyl-Dalbavancin A0Cat. No. P-D006-011
NitrosamineN-Nitroso-Desmethyl-Dalbavancin A1Cat. No. P-D006-012
NitrosamineN-Nitroso-Desmethyl-Dalbavancin B1Cat. No. P-D006-014
NitrosamineN-Nitroso-Desmethyl-Dalbavancin B2Cat. No. P-D006-015
ImpurityDalbavancin A0Cat. No. P-D006-016CAS 171500-81-5
ImpurityDalbavancin B1Cat. No. P-D006-018CAS 171500-82-6
ImpurityDalbavancin B2Cat. No. P-D006-019CAS 871132-03-5
ImpurityDalbavancin Impurity 1Cat. No. P-D006-024CAS 102961-72-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.